|
|
Volumn 293, Issue 5532, 2001, Pages 1024-
|
|
Hopkins reviews investment in Indian cancer drug trial
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
M4N;
NORDIHYDROGUAIARETIC ACID;
TETRAMETHYLNORDIHYDROGUAIARETIC ACID;
UNCLASSIFIED DRUG;
CANCER CHEMOTHERAPY;
CANCER RESEARCH;
CLINICAL ARTICLE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG RESEARCH;
ETHICS;
HOSPITAL;
HUMAN;
INDIA;
MEDICAL ETHICS;
MEDICAL RESEARCH;
NOTE;
PRIORITY JOURNAL;
SOLID TUMOR;
ARTICLE;
BIOETHICS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
ECONOMICS;
FINANCIAL MANAGEMENT;
INTERNATIONAL COOPERATION;
JOHNS HOPKINS UNIVERSITY;
MOUTH TUMOR;
PATENT;
PROFESSIONAL STANDARD;
STANDARD;
UNITED STATES;
UNIVERSITY HOSPITAL;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
JOHNS HOPKINS UNIVERSITY;
ACADEMIC MEDICAL CENTERS;
ANTINEOPLASTIC AGENTS;
BALTIMORE;
BIOETHICS;
CLINICAL TRIALS;
HUMANS;
INDIA;
INTERNATIONALITY;
MOUTH NEOPLASMS;
PATENTS;
PROFESSIONAL STAFF COMMITTEES;
RESEARCH SUPPORT;
|
|
EID: 17944362134
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.293.5532.1024 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|